Axsome Therapeutics News

Axsome Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 1 18:18 ET

Axsome Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 15 19:12 ET

Axsome Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 14 16:26 ET

Axsome Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Sep 15, 2023 18:32 ET

Axsome Therapeutics | 424B5: Prospectus

Jun 28, 2023 20:16 ET

Axsome Therapeutics | 424B5: Prospectus

Jun 27, 2023 20:51 ET

Axsome Therapeutics | 424B5: Prospectus

Aug 19, 2022 21:35 ET

Axsome Therapeutics | 424B5: Prospectus

Mar 1, 2022 17:21 ET

Axsome Therapeutics | 424B5: Prospectus

Dec 19, 2019 20:23 ET

Axsome Therapeutics | 424B5: Prospectus

Dec 18, 2019 17:41 ET

Axsome Therapeutics | 424B5: Prospectus

May 9, 2019 16:59 ET

Axsome Therapeutics | 424B5: Prospectus

Sep 28, 2018 17:25 ET

Axsome Therapeutics | 424B5: Prospectus

Dec 4, 2017 09:12 ET

Axsome Therapeutics | 424B5: Prospectus

Oct 20, 2017 17:03 ET

Axsome Therapeutics | 424B5: Prospectus

Mar 21, 2017 14:00 ET

Axsome Therapeutics | 424B5: Prospectus

Mar 20, 2017 17:25 ET